Renaissance Technologies’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-200,499
| Closed | -$325K | – | 4007 |
|
|
2023
Q2 | $325K | Buy |
+200,499
| New | +$325K | ﹤0.01% | 3096 |
|
|
2022
Q4 | – | Sell |
-590,568
| Closed | -$439K | – | 4334 |
|
|
2022
Q3 | $439K | Sell |
590,568
-338,432
| -36% | -$252K | ﹤0.01% | 3002 |
|
|
2022
Q2 | $722K | Buy |
929,000
+324,819
| +54% | +$252K | ﹤0.01% | 2915 |
|
|
2022
Q1 | $547K | Buy |
+604,181
| New | +$547K | ﹤0.01% | 3126 |
|
|
2021
Q1 | – | Sell |
-335,300
| Closed | -$1.41M | – | 3618 |
|
|
2020
Q4 | $1.41M | Buy |
335,300
+194,300
| +138% | +$816K | ﹤0.01% | 2324 |
|
|
2020
Q3 | $675K | Sell |
141,000
-4,700
| -3% | -$22.5K | ﹤0.01% | 2703 |
|
|
2020
Q2 | $886K | Buy |
145,700
+108,700
| +294% | +$661K | ﹤0.01% | 2597 |
|
|
2020
Q1 | $203K | Sell |
37,000
-46,000
| -55% | -$252K | ﹤0.01% | 3099 |
|
|
2019
Q4 | $823K | Sell |
83,000
-19,300
| -19% | -$191K | ﹤0.01% | 2717 |
|
|
2019
Q3 | $589K | Buy |
102,300
+84,500
| +475% | +$487K | ﹤0.01% | 2810 |
|
|
2019
Q2 | $162K | Buy |
17,800
+2,500
| +16% | +$22.8K | ﹤0.01% | 3336 |
|
|
2019
Q1 | $212K | Buy |
+15,300
| New | +$212K | ﹤0.01% | 3200 |
|
|
2016
Q3 | – | Sell |
-13,000
| Closed | -$63K | – | 3463 |
|
|
2016
Q2 | $63K | Buy |
+13,000
| New | +$63K | ﹤0.01% | 3215 |
|
|
2015
Q3 | – | Sell |
-14,697
| Closed | -$245K | – | 3319 |
|
|
2015
Q2 | $245K | Buy |
+14,697
| New | +$245K | ﹤0.01% | 2939 |
|